NASDAQ:AKUMQ Akumin (AKUMQ) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free AKUMQ Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.38▼$0.3850-Day Range$0.38▼$0.3852-Week Range$0.12▼$1.43Volume1,000 shsAverage Volume196,980 shsMarket Capitalization$34.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsSocial MediaStock AnalysisEarningsSocial Media Get Akumin alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About Akumin Stock (NASDAQ:AKUMQ)Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida. On October 22, 2023, Akumin Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.Read More Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 AKUMQ Stock News HeadlinesMay 3, 2024 | americanbankingnews.comAkumin (NASDAQ:AKUMQ) Stock Price Down 6.3%See More Headlines Receive AKUMQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:AKUMQ Previous SymbolNASDAQ:AKUMQ CUSIPN/A CIK1776197 Webwww.akumin.com Phone844-730-0050FaxN/AEmployees3,631Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.82) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-156,760,000.00 Net Margins-34.67% Pretax Margin-35.23% Return on Equity-1,249.92% Return on Assets-8.42% Debt Debt-to-Equity RatioN/A Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual Sales$749.63 million Price / Sales0.05 Cash FlowN/A Price / Cash FlowN/A Book Value$1.24 per share Price / Book0.30Miscellaneous Outstanding Shares91,170,000Free Float72,473,000Market Cap$34.19 million OptionableNot Optionable Beta-1.02 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Riadh Zine-El-Abidine (Age 52)Chairman & CEO Comp: $1.78MMr. Krishna Kumar AnanthasubramanianPresident & COOMr. Ronald J. Bienias (Age 52)Interim CFO & Chief Restructuring Officer Mr. Paul Nelis (Age 56)Chief Information Officer Darren SpeedChief Compliance OfficerMs. Tracy Wiese (Age 55)Chief Strategy & Marketing Officer Ms. Holly Huso (Age 59)Enterprise Sales Officer Ms. Laurie R. Miller (Age 57)Chief Human Resources Officer Mr. Mohammad SaleemSenior Vice President of Financial ReportingMr. Christopher FitzgeraldChief Revenue OfficerMore ExecutivesKey CompetitorsExagenNASDAQ:XGNDermTechNASDAQ:DMTKEnzo BiochemNYSE:ENZPsychemedicsNASDAQ:PMDBioNexus Gene LabNASDAQ:BGLCView All Competitors This page (NASDAQ:AKUMQ) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society“Crash Insurance” For Your RetirementUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akumin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
